Please don't make me explain the insider transaction deal to you other than to say this...They sell for many reasons but buy for just one.
In a nutshell, his sale is meaningless.
Not sure what to think about the data as from my layman's point of view, it looks just ok and probably won't cause huge moves one way or the other.
My only thought is that as someone who has been reading biotech press releases for 30 years, the writing of this one did seem to be a bit "hyped". I will watch today's action and decide what to do from here.
First of all, real nice analysis and I agree that 20% premium is cheap for FOLD. After all you get a close to market drug that helps to prove the value of the entire companies platform.
That being said, I am pretty confident in saying that Mr. Crowley won't let this company go for a song and a dance. My guess is that if he can't get 2 billion then he will just keep building FOLD into a bigger and bigger player. Either way I'm more than content to just let it play out.
Mr Crowley is known to build 'em and sell 'em so a takeover within the next few months wouldn't come as a surprise to me.
Just having Mr. Crowley as CEO adds a 5 dollar premium. We'll be over 15 by the end of June, if we don't get taken out before then.
Been trading bios for 25 years and have seen 100s of these ambulance chasing lawsuits, You are correct...they are frivolous.
Not sure why you don't like the company. Maybe the product doesn't have an immense market to sell into but I think you need to look beyond Fabry's and look at Pompe's and even FOLD starting to go after Parkinsons.
Also, as I have repeatedly stated, John Crowley is one smart and honest guy. GLTY
I read somewhere that the CEO believes that the patient population is larger plus it's about the platform and applying it to other diseases. IMO this is all options driven trading.
Mid to late 1980s early 1990s biotech bubble. Companies would announce the start of phase 1 trials and the stocks would go from 10 to 300 in a matter of weeks. Witness CYTR and XOMA. Look at their Max charts and you'll see.
That my friends is a bubble. Companies like FOLD are far from that and are the real deal.